Free Trial

First Nebraska Trust Co Purchases 57,445 Shares of The Clorox Company $CLX

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

  • First Nebraska Trust Co. bought 57,445 Clorox shares in the third quarter, worth approximately $4.65 million.
  • Clorox reported quarterly adjusted EPS of $1.55, beating the $1.07 consensus, and revenue of $1.91 billion, above estimates of $1.88 billion.
  • Despite the earnings beat, rising costs are pressuring margins, and the company expects adjusted earnings near the lower end of its outlook. Its $5 annualized dividend yields about 5.3%, while analyst sentiment is largely cautious.
  • Interested in Clorox? Here are five stocks we like better.

First Nebraska Trust Co purchased a new stake in The Clorox Company (NYSE:CLX - Free Report) in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm purchased 57,445 shares of the company's stock, valued at approximately $4,653,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Eads & Heald Wealth Management raised its stake in Clorox by 9.5% in the 3rd quarter. Eads & Heald Wealth Management now owns 5,464 shares of the company's stock valued at $443,000 after acquiring an additional 472 shares during the period. XML Financial LLC lifted its holdings in Clorox by 3.8% during the 3rd quarter. XML Financial LLC now owns 8,475 shares of the company's stock valued at $687,000 after purchasing an additional 310 shares during the last quarter. Landaas & Co. WI ADV acquired a new stake in Clorox during the 3rd quarter valued at $320,000. Mirae Asset Global Investments Co. Ltd. bought a new position in Clorox during the third quarter worth $4,104,000. Finally, Ipsen Advisor Group LLC boosted its position in Clorox by 7.0% during the third quarter. Ipsen Advisor Group LLC now owns 5,403 shares of the company's stock worth $438,000 after purchasing an additional 355 shares during the period. Institutional investors own 78.53% of the company's stock.

More Clorox News

Here are the key news stories impacting Clorox this week:

  • Positive Sentiment: Clorox reported adjusted EPS of $1.55, above the $1.07 consensus, and revenue of $1.91 billion versus estimates of $1.88 billion. Sales growth, cost savings and contributions from GOJO supported the quarter. Clorox shares rally after Q1 earnings beat
  • Positive Sentiment: The company gave fiscal 2027 adjusted EPS guidance of $5.70–$6.00 and revenue guidance of $7.6–$7.7 billion, broadly in line with or above analyst expectations. Productivity efforts, pricing and GOJO integration savings are intended to help offset cost pressure. Clorox Q1 earnings call highlights
  • Neutral Sentiment: Analyst price-target changes were mixed: UBS raised its target to $96 while maintaining a Neutral rating; TD Cowen lifted its target to $88, and JPMorgan raised its target to $86 but retained an Underweight rating. UBS target update
  • Negative Sentiment: Clorox expects adjusted earnings near the lower end of its outlook as inflation and other rising costs pressure margins, despite the quarterly beat. Its CEO also pointed to a potential warning sign in consumer spending, which could weigh on demand. Clorox trims outlook on higher costs Clorox CEO economic warning
  • Negative Sentiment: Investors may also be weighing debt from a recent acquisition and the potential implications for dividend flexibility. Clorox outlook and dividend concerns

Clorox Stock Performance

CLX opened at $93.77 on Wednesday. The firm has a market cap of $11.34 billion, a P/E ratio of 16.87, a price-to-earnings-growth ratio of 3.00 and a beta of 0.59. The Clorox Company has a 52-week low of $79.12 and a 52-week high of $128.90. The company has a debt-to-equity ratio of 15.80, a quick ratio of 0.38 and a current ratio of 0.66. The business's fifty day moving average is $88.00 and its 200-day moving average is $99.83.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, November 2nd. The company reported $1.55 EPS for the quarter, beating analysts' consensus estimates of $1.07 by $0.48. Clorox had a return on equity of 601.88% and a net margin of 9.41%. The business had revenue of $1.91 billion during the quarter, compared to the consensus estimate of $1.88 billion. During the same quarter in the previous year, the firm earned $0.85 earnings per share. Clorox's revenue for the quarter was up 33.3% compared to the same quarter last year. Sell-side analysts expect that The Clorox Company will post 5.68 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be issued a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 5.3%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox's dividend payout ratio (DPR) is currently 103.73%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on the stock. Morgan Stanley decreased their price objective on shares of Clorox from $97.00 to $87.00 and set an "equal weight" rating on the stock in a report on Thursday, October 15th. Zacks Research cut shares of Clorox from a "hold" rating to a "strong sell" rating in a research note on Thursday, October 29th. Wall Street Zen downgraded shares of Clorox from a "hold" rating to a "sell" rating in a report on Saturday, October 3rd. Jefferies Financial Group lowered shares of Clorox from a "buy" rating to a "hold" rating and decreased their price target for the company from $125.00 to $98.00 in a research note on Tuesday, July 28th. Finally, TD Cowen reiterated a "hold" rating on shares of Clorox in a research note on Tuesday. One analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have given a Sell rating to the company's stock. According to MarketBeat.com, the stock presently has an average rating of "Reduce" and an average price target of $93.29.

Read Our Latest Analysis on CLX

Clorox Profile

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Articles

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines